Vascular apoptosis and involution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis

Laboratory Investigation

Volumn 80, Issue 6, 2000, Pages 837-849

  Zagzag, David ^a   Amirnovin, Ramin ^a   Greco, M Alba ^a   Yee, Herman ^a   Holash, Jocelyn ^b   Wiegand, Stanley J ^b   Zabski, Stephanie ^b   Yancopoulos, George D ^b   Grumet, Martin ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b REGENERON PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASTROCYTE; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; GLIOMA; INVOLUTION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERICYTE; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

EID: 0033917495     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3780088     Document Type: Article

References (88)

1. Abedi H and Zachary I (1997). Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesion kinase and paxillin in endothelial cells. J Biol Chem 272:15442-15451.
2. Akbasak A, Olderfield SH, and Saris SC (1991). Expression and modulation of major histocompatability antigens on primary brain tumor in vitro. J Neurosurg 75:922-929.
3. Allen RT, Hunter WJ III, and Agrawal DK (1998). Morphologic and temporal analysis of vascular smooth muscle cell apoptosis induced by c-myc and E1A. Scanning 20:577-586.
4. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, and Yuan J (1996). Human ICE/CED-3 protease nomenclature. Cell 87:171.
5. Alon T, Hemo I, Itin A, Peer J, Stone J, and Keshet E (1995). Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024-1028.
6. Alvarez RJ, Gips SJ, Moldovan N, Wilhide CC, Milliken EE, Hoang AT, Hurban RH, Silverman HS, Dang CV, and Goldschmidt-Clermont PJ (1997). 17beta-estradiol inhibits apoptosis of endothelial cells. Biochem Biophys Res Commun 237:372-381.
7. Azmi TI and O'Shea JD (1984). Mechanism of deletion of endothelial cells during regression of the corpus luteum. Lab Invest 51:206-217.
8. Bates RC, Buret A, van Helden DF, Horton MA, and Burns GF (1994). Apoptosis induced by inhibition of intercellular contact. J Cell Biol 125:403-415.
9. Benjamin LE, Golijanin D, Itin A, Pode D, and Keshet E (1999). Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159-165.
10. Benjamin LE and Keshet E (1997). Conditional switching of vascular endothelial growth factor (VEGF) in tumors: Induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 94:8761-8766.
11. Bennet MR and Boyle JJ (1998). Apoptosis of vascular smooth muscle cells in atherosclerosis. Atherosclerosis 138: 3-9.
12. Brooks PC, Montgomery AMP, Rosenfeld M, Reisfeld RA, Hu T, Klier G, and Cheresh DA (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis angiogenic blood vessels. Cell 79:1157-1164.
13. Burger PC, Vogel FS, Green SB, and Strike TA (1985). Glioblastoma multiforme and anaplastic astrocytoma: Pathologic criteria and prognostic implications. Cancer 56:1106-1111.
14. Chishima T, Moyagi Y, Wang X, Yamaoka H, Shimada H, Moossa AR, and Hoffman RM (1997). Cancer invasion and micrometastasis visualized in live tissue by green fluorescent protein expression. Cancer Res 57:2042-2047.
15. Davis S, Aldrich TH, Jones PF, Acheson A, Compton LD, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, and Yancopoulous GD (1996). Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169.
16. deBlois D, Tea BS, Than VD, Tremblay J, and Hamet P (1997). Smooth muscle apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 29:340-349.
17. Desmouliere A, Redard M, Darby I, and Gabbiani G (1995). Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 146:56-66.
18. Dinsdale D, Zhuang J, and Cohen GM (1999). Redistribution of cytochrome c precedes the caspase-dependent formation of ultracondensed mitochondria, with a reduced inner membrane potential, in apoptotic monocytes. Am J Pathol 155: 607-618.
19. Dumont DJ, Gradwohl G, Fong GH, Puri MC, Gertsenstein M, Auerbach A, and Breitman ML (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev 8:1897-1909.
20. Folkman J (1971). Tumor Angiogenesis: Therapeutic implications. N Engl J Med 285:1182-1186.
21. Folkman J (1990). What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6.
22. Folkman J (1995). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27-31.
23. Fox JC and Shanley JR (1996). Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells. J Biol Chem 271:12578-12584.
24. Franklin KBJ and Paxinos G (1997). The mouse brain in stereotaxic coordinates. San Diego: Academic Press.
25. Frisch SM and Francis H (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626.
26. Frisch SM and Ruoslahti E (1997). Integrins and anoikis. Curr Opin Cell Biol 9:701-706.
27. Frisch SM, Vouri K, Ruoslahti E, and Chan-Hui PY (1996). Control of adhesion dependent cell survival by focal adhesion kinase. J Cell Biol 134:793-799.
28. Gavrieli Y, Sherman Y, and Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Bio 119:493-501.
29. Geng YJ, Wu Q, Muszynski M, Hansson GK, and Libby P (1996). Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-γ, tumor necrosis factor-a, and interleukin-1β. Arterioscler Thromb Vase Biol 16:19-27.
30. Gimbrone MA Jr, Cotran RS, Leapman SB, and Folkman J (1974). Tumor growth and neovascularization: An experimental model using the rabbit cornea. J Natl Cancer Inst 52:413-427.
31. Goede V, Schmidt T, Kimmina S, Kozian D, and Augustin HG (1998). Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab Invest 78:1385-1394.
32. Granville DJ, Shaw JR, Leong S, Carthy CM, Margaron P, Hunt DW, and McManus BM (1999). Release of cytochrome c, Bax migration, Bid cleavage, and activation of caspases 2, 3, 6, 7, 8, and 9 during endothelial cell apoptosis. Am J Pathol 155:1021-1025.
33. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, and Schulte-Herman R (1995). In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: A cautionary note. Hepatology 21:1465-1468.
34. Gubin A, Reddy B, Njoroge J, and Miller JL (1997). Long-term stable expression of green fluorescent protein in mammalian cells. Biochem Biophys Res Commun 236:347-350.
35. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, Yancopoulos GD, and Wiegand SJ (1999). Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998.
36. Honma T and Hamasaki T (1998). Ultrastructure of blood vessel regression in involution of foreign-body granuloma. J Submicrosc Cytol Pathol 30:31-44.
37. Hungerford JE, Compton MT, Matter ML, Hoffstrom BG, and Otey CA (1996). Inhibition of pp125FAK in cultured fibroblasts results in apoptosis. J Cell Biol 135:1383-1390.
38. Hynes RO (1992). Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
39. Jones PL, Crack J, and Rabinovitch M (1997). Regulation of tenascin-C, a vascular smooth muscle cell survival factor that interacts with the alpha v beta 3 integrin to promote epidermal growth factor receptor phosphorylation and growth. J Cell Biol 139:279-293.
40. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, and Goldstein P (1994). Fas and perforin pathways as major mechanisms of T-cell-mediated cytotoxicity. Science 265:528-530.
41. Kayanoki Y, Fujii J, Islam K, Suzuki K, Kawata S, Matsuzawa Y, and Taniguchi N (1996). The protective role of glutathione peroxidase in apoptosis induced by reactive oxygen species. J Biochem 119:817-822.
42. Kebers F, Lewalle JM, Desreux J, Munaut C, Devy L, Foidart JM, and Noel A (1998). Induction of endothelial cell apoptosis by solid tumor cells. Exp Cell Res 240:197-205.
43. Kelly PJ, Suddith RL, Hutchison HT, Werrbach K, Haber B (1976). Endothelial growth factor present in tissue culture of CNS tumors. J Neurosurg 44:342-346.
44. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, and Risau W (1998). Angiopoietin-1 induces sprouting angiogenesis in vitro. Curr Biol 8:529-532.
45. Kwak HJ, So JN, Lee SJ, Kim I, and Koh GY (1999). Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett 448:249-253.
46. Leedy DA, Trune DR, Kronzo JD, Weidner N, and Cohen JI (1994). Tumor angiogenesis, the p53 antigen, and cervical metastasis in squamous carcinoma of the tongue. Otolaryngol Head Neck Surg 111:417-422.
47. Leithauser F, Dhein J, Mechtersheimer G, Koretz K, Burderlein S, Henne C, Schmidt A, Debatin KM, Kramer PH, and Moller P (1993). Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest 69:415-429.
48. Li PF, Dietz R, and von Harsdorf R (1997). Reactive oxygen species induce apoptosis of vascular smooth muscle cell. FEBS Letters 404:249-252.
49. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, and Yancopoulos GD (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55-60.
50. Majno G and Joris I (1995). Apoptosis, oncosis, and necrosis: An overview of cell death. Am J Pathol 146:3-15.
51. Meeson A, Plamer M, Calfon M, and Lang R (1996). A relationship between apoptosis and flow during programmed capillary regression is revealed by vital analysis. Development 122:3929-3938.
52. Mitchell CA, Risau W, and Drexler HC (1998). Regression of vessels in the tunica vasculosa lentis is initiated by coordinated endothelial apoptosis: Role for vascular endothelial growth factor as a survival factor for endothelium. Dev Dyn 213:322-333.
53. Modlich U, Kaup FJ, and Augustin HG (1996). Cyclic angiogenesis and blood vessel regression in the ovary: Blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Lab Invest 74:771-780.
54. Molnar PP, O'Neil BP, Scheitauer BW, and Grothuis DR (1999). The blood brain barrier in primary CNS lymphomas: Ultrastrucutral evidence of endothelial cell death. NeuroOncol 1:89-100.
55. Nagano N, Sasaki H, Aoyagi M, and Hirakawa K (1993). Invasion of experimental rat brain tumor: Early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 86:117-125.
56. Nagata S (1997). Apoptosis by death factor. Cell 88:355-365.
57. Nicosia RF and Madri J (1987). The microvascular extracellular matrix: Developmental changes during angiogenesis in the aortic ring-plasma clot model. Am J Pathol 128:78-90.
58. Nicosia RF, Tchao R, and Leighton J (1983). Angiogenesis-dependent tumor spread in reinforced fibrin clot culture. Cancer Res 43:2159-2166.
59. Nicosia RF, Tchao R, and Leighton J (1986). Interactions between newly formed endothelial channels and carcinoma cells in plasma clot culture. Clin Expl Metastasis 4:91-104.
60. Nor JE, Christensen J, Mooney DJ, and Polverini PJ (1999). Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction Bcl-2 expression. Am J Pathol 154:375-384.
61. Papapetropoulos A, Garcia-Cardena G, Dengler TJ, Maisonpierre PC, Yancopoulos GD, and Sessa WC (1999). Direct actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest 79:213-223.
62. Payne CM, Bernstein H, Bernstein C, and Garewal H (1995). Role of apoptosis in biology and pathology: Resistance to apoptosis in colon carcinogenesis. Ultrastruct Pathol 19: 221-248.
63. Pezzella F, Pastorino U, Tagliabue E, Andreola S, Sozzi G, Gasparini G, Menard S, Gatter K, Harris A, Fox S, Buyse M, Pilotti S, Pierotti M, and Rilke F (1997). Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am J Pathol 151:1417-1423.
64. Plate KH, Breier G, Weich HA, and Risau W (1992). Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
65. 1 in endothelial cells versus smooth muscle cells. Circulation 99:2019-2026.
66. Re F, Zanetti A, Sironi M, Polentarutti N, Lanfrancone L, Dejana E, and Colotta F (1994). Inhibition of anchorage-dependant cell spreading triggers apoptosis in cultured human endothelial cells. J Cell Biol 127:537-546.
67. Richardson BC, Lalwani ND, Johnson KJ, and Marks RM (1994). Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 24:2640-2645.
68. Robaye B, Mosselmans R, Fiers W, Dumond JE, and Galand P (1991). Tumor necrosis factor induces apoptosis (programmed cell death) in normal endothelial cells in vitro. Am J Pathol 138:447-453.
69. Ruoslahti E and Reed JC (1994). Anchorage dependance, integrins, and apoptosis. Cell 77:477-478.
70. Ruoslahti E (1996). Integrin signaling and matrix assembly. Tumour Biol 17:117-124.
71. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fijiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, and Qin Y (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74.
72. Schaller MD, Borgman CA, Cobb BS, Vines RR, Reynolds AB, and Parsons JT (1992). pp125FAK: A structurally distinctive protein-tyrosine kinase associated with focal adhesions. Proc Natl Acad Sci USA 89:51192-51196.
73. Shabisgh A, Tanji N, D'Agati V, Burchardt M, Rubin M, Goluboff E, Heitjan D, Kriss A, and Buttyan R (1999). Early effects of castration on the vascular system of the rat ventral prostate gland. Endocrinology 140:1920-1926.
74. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
75. Smith-McCune KK and Weidner N (1994). Demonstration and characterization of the angiogenic properties of cervical dysplasia. Cancer Res 54:800-804.
76. Stempien-Otero A, Karsan A, Cornejo CJ, Xiang H, Eunson T, Morrison RS, Kay M, Winn R, and Harlan J (1999). Mechanisms of hypoxia-induced endothelial cell death. J Biol Chem 274:8039-8045.
77. Suri C, McClain J, Thurston G, McDonald DM, Zhou H, Oldmixon EH, Sato TN, and Yancopoulos GD (1998). Angiopoietin-1 promotes increased vascularization in vivo. Science 282:468-471.
78. Tohma Y, Gratas C, Van Meir EG, Desbailets I, Tenan M, Tachibana O, Kleihues P, and Ohgaki H (1998). Necrogenesis and Fas/APO-1 (CD95) expression in primary (de novo) and secondary glioblastomas. J Neuropathol Exp Neuro 57:239-245.
79. Valenzuela DM, Maisonpierre PC, Glass DJ, Rojas E, Nunez L, Kong Y, Gies DR, Stitt TN, Ip NY, and Yancopoulos GD (1993). Alternative forms of rat TrkC with different functional capabilities. Neuron 10:963-974.
80. Walker NI and Gobe GC (1987). Cell death and cell proliferation during atrophy of the rat parotid gland induced by duct obstruction. J Pathol 153:333-344.
81. Walker NI, Bennett RE, and Kerr JFR (1989). Cell death by apoptosis during involution of the lactating breast in mice and rats. Am J Anat 185:19-32.
82. Wyllie AH, Kerr JFR, and Currie AR (1980). Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306.
83. Xu LH, Owens LV, Sturge GC, Yang X, Liu ET, Craven RJ, and Cance WG (1996). Attenuation of the expression of the focal adhesion kinase induces apoptosis in tumor cells. Cell Growth Differ 7:413-418.
84. Yamada KM and Miyamoto S (1995). Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 7:681-689.
85. Yancopoulos GD, Klagsbrun M, and Folkman J (1998). Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border. Cell 93:661-664.
86. Zagzag D (1995). Angiogenic factors in neural embryogenesis and neoplasia. Am J Pathol 146:293-309.
87. Zagzag D, Friedlander DR, Dosik J, Chikramane S, Chan W, Greco MA, Allen JC, Dorovini-Zis K, and Grumet M (1996). Tenascin-C expression in angiogenic vessels in human astrocytomas and by human brain endothelial cells in vitro. Cancer Res 56:182-189.
88. Zagzag D, Hooper A, Friedlander DR, Chan W, Holash J, Wiegand SJ, Yancopoulos GD, and Grumet M (1999). In situ expression of angiopoietins in astrocytomas identifies angiopoietin-2 as an early marker of tumor angiogenesis. Exp Neurol 159:391-400.